My main concerns remain two fold:
- Issuance of basically free stock to management (when there has been no discernible sp accretion for shareholders);
- reliability on large funds/cornerstones to the detriment of retail investors (who do you think will start buying MDR when one of the big players wants out for lack of performance? Good luck doing a crossing at that stage - imo this management team is dropping the ball massively by gambling on the big boys. A VERY risky strategy at best - and unacceptable I would think given the down side risk it exposes shareholders and the company to). Where is the risk committee?
Add to My Watchlist
What is My Watchlist?
